Integrin alpha-L
Details
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00095 Efalizumab approved, investigational, withdrawn yes antibody Details DB02177 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine experimental unknown Details DB03932 LFA703 experimental unknown Details DB04724 (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide experimental unknown Details DB00227 Lovastatin approved, investigational unknown inhibitor Details DB00098 Antithymocyte immunoglobulin (rabbit) approved yes Details DB06972 7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile experimental unknown Details DB07486 3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline experimental unknown Details DB11611 Lifitegrast approved yes antagonist Details DB00641 Simvastatin approved unknown inhibitory allosteric modulator Details DB01098 Rosuvastatin approved unknown inhibitory allosteric modulator Details DB08860 Pitavastatin approved unknown Details